Can Patient-Derived Organoids Help Oncologists Make Treatment Decisions?
Organoids created from tumor samples have been revolutionizing laboratory research, but they also may begin helping oncologists decide on treatment regimens for patients.
All articles by Victoria Forster, PhD
Drug Shortages Threaten Childhood Cancer Treatment
Experts are calling for a protected drugs list to stop shortages that could impact the chance of survival for childhood cancer patients.
TVEC for Advanced Melanoma Yields Stunning Results in 3-Center Study
Could combining the oncolytic viral therapy TVEC with other therapies enhance the immunotherapy’s efficacy, allowing more patients to benefit?
Deep Analysis of BCR-ABL Transcripts Predicts Tyrosine Kinase Inhibitor Response in CML
Although patients with CML may not be eligible for TKI discontinuation based on transcript alone, the type of transcript seen may have some implications for loss of treatment remission.
Immune Signature for Renal Cell Papillary Carcinoma Predicts Outcome
Researchers identified 15 genes that they said independently predict the survival outcome of patients with kidney renal papillary cell carcinoma.
CRISPR in Cancer: Not Quite Ready for Clinical Trials
Researchers provide further proof that CRISPR can augment cancer treatment in the lab, but many barriers remain before clinical trials can be conducted in patients.
Next post in Lung Cancer
